79
Participants
Start Date
December 31, 1999
Primary Completion Date
November 30, 2001
Tipranavir (TPV) low dose
Tipranavir (TPV) high dose
Ritonavir low dose
Ritonavir high dose
Saquinavir
Lead Sponsor
Boehringer Ingelheim
INDUSTRY